这是一篇来自已证抗体库的有关人类 磷脂酶C乙4 (phospholipase C beta 4) 的综述，是根据1篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合磷脂酶C乙4 抗体。
磷脂酶C乙4 同义词: ARCND2; PI-PLC; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4; 1-phosphatidyl-D-myo-inositol-4,5-bisphosphate; PLC-beta-4; dJ1119D9.2 (Phopholipase C, beta 4 (1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Beta 4)); inositoltrisphosphohydrolase; monophosphatidylinositol phosphodiesterase; phosphoinositidase C; phosphoinositide phospholipase C-beta-4; triphosphoinositide phosphodiesterase

圣克鲁斯生物技术
小鼠 单克隆（A-8）
  • 免疫组化; 人类; 1:50; 图 8a
圣克鲁斯生物技术磷脂酶C乙4抗体（Santa Cruz, sc- 166131)被用于被用于免疫组化在人类样品上浓度为1:50 (图 8a). Oncotarget (2016) ncbi
文章列表
  1. Frantzi M, Klimou Z, Makridakis M, Zoidakis J, Latosinska A, Borràs D, et al. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models. Oncotarget. 2016;7:70750-70768 pubmed 出版商